These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11260275)

  • 1. Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review.
    Dykes AC; Walker ID; Lowe GD; Tait RC
    Haemophilia; 2001 Mar; 7(2):160-3. PubMed ID: 11260275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged Activated Partial Thromboplastin Time: Difficulties in Discriminating Coexistent Factor VIII Inhibitor and Lupus Anticoagulant.
    Ames PR; Graf M; Archer J; Scarpato N; Iannaccone L
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):149-54. PubMed ID: 24989713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases: A potential cause of life-threatening hemorrhage.
    O'Connor CR
    Semin Arthritis Rheum; 2015 Jun; 44(6):695-709. PubMed ID: 25595725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired haemophilia: experiences with a standardized approach.
    Grünewald M; Beneke H; Güthner C; Germowitz A; Brommer A; Griesshammer M
    Haemophilia; 2001 Mar; 7(2):164-9. PubMed ID: 11260276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune tolerance induction with high-dose FVIII and pulsed intravenous immunoglobulin].
    Stiefel M; Pinkwart C; Haase R; Merkel N; Forsberg D; Mauz-Körholz C
    Hamostaseologie; 2010 Nov; 30 Suppl 1():S119-21. PubMed ID: 21042665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies.
    Sahud M; Zhukov O; Mo K; Popov J; Dlott J
    Haemophilia; 2012 Sep; 18(5):777-81. PubMed ID: 22458845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a recombinant factor VIII preparation (Kogenate) in previously untreated patients with hemophilia A.
    Yoshioka A; Fukutake K; Takamatsu J; Shirahata A;
    Int J Hematol; 2003 Dec; 78(5):467-74. PubMed ID: 14704043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin.
    Takeyama M; Nogami K; Kajimoto T; Ogiwara K; Matsumoto T; Shima M
    Int J Hematol; 2018 Jan; 107(1):112-116. PubMed ID: 28597369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.
    Kobayashi T; Kobayashi T; Morikawa A; Ikeda K; Seki M; Shimoyama S; Ishii Y; Suzuki T; Nakajima K; Sakamoto N; Arakawa H
    J Pediatr; 2013 Aug; 163(2):521-6. PubMed ID: 23485027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and outcome of acquired haemophilia A with a standard conventional regimen in a cohort without associated conditions.
    Ng HJ; Tan DC; Lee LH
    Haemophilia; 2006 Jul; 12(4):423-8. PubMed ID: 16834745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired inhibitors.
    Cohen AJ; Kessler CM
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of acquired factor VIII inhibitor].
    Murakami R; Sugiyama T; Kurokawa I; Arimura Y; Kawasaki K; Hirata H; Suzuki T; Sumimoto Y; Taniuchi A
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1739-41. PubMed ID: 8537732
    [No Abstract]   [Full Text] [Related]  

  • 14. Individualised treatment of seven cases of acquired factor VIII inhibitors.
    Tien SL; Tan P; Ong YW; Loh TF
    Ann Acad Med Singap; 1991 Nov; 20(6):745-9. PubMed ID: 1803961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired factor VIII inhibitors in nonhemophilic patients.
    Söhngen D; Specker C; Bach D; Kuntz BM; Burk M; Aul C; Kobbe G; Heyll A; Hollmig KA; Schneider W
    Ann Hematol; 1997 Feb; 74(2):89-93. PubMed ID: 9063379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical cases of acquired coagulation inhibitors].
    Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
    Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic abnormalities and lupus anticoagulant activity in patients with Gaucher disease type I.
    Barone R; Giuffrida G; Musso R; Carpinteri G; Fiumara A
    J Inherit Metab Dis; 2000 Jun; 23(4):387-90. PubMed ID: 10896301
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of lupus anticoagulant and acquired haemophilia in a patient with monoclonal gammopathy of unknown significance.
    Taher A; Abiad R; Uthman I
    Lupus; 2003; 12(11):854-6. PubMed ID: 14667103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.